0.00(0%)

Last update at

Day Range

LowHigh

52 Week Range

LowHigh

Fundamentals

Previous Close -
Market Cap-
Volume
P/E Ratio-
Dividend Yield-%
Revenue TTM-
Revenue Per Share TTM-
Gross Profit TTM -
Diluted EPS TTM-

Overview
Financials
Peer Comparison
Reports
Stock Research & News

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

IO Biotech price target raised to $14 from $12 at H.C. Wainwright
Thu 15 May 25, 04:11 PM
IO Biotech Reports First Quarter 2025 Financial Results and Business Highlights
Wed 14 May 25, 12:05 PM
IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025
Sat 26 Apr 25, 07:05 PM
IO Biotech Presents New Data at AACR 2025 Supporting Dual Mechanism and Immune Activation of Cancer Vaccines IO102-IO103 and IO170
Fri 25 Apr 25, 05:00 PM
IO Biotech Announces Acceptance of Abstracts to be Presented at the 2025 American Association for Cancer Research (AACR) Annual Meeting
Tue 25 Mar 25, 08:35 PM
IO Biotech Reports 2024 Business Highlights
Tue 04 Mar 25, 09:17 PM
IO Biotech Announces New Preclinical Data for Additional Pipeline Candidate Presented at the AACR-IO Conference
Sun 23 Feb 25, 05:07 PM
IO Biotech to Present at the 45th Annual Cowen Health Care Conference
Thu 20 Feb 25, 01:05 PM
IO Biotech Announces Publication of Preclinical Data Investigating Immune-Modulatory Effects of IO112, an Arginase 1-Targeting Therapeutic Cancer Vaccine Candidate
Tue 04 Feb 25, 01:05 PM

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown

Breakdown

Breakdown

Peer Comparison

Sector: Industry:

Company	Change ()	Price ()	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)

Reports Covered

View All

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.